ENVVENO MEDICAL CORP (NVNO) Stock Balance Sheet
NASDAQ:NVNO - Nasdaq - US29415J1060 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.62M | 4.56M | 54.73M | 9.33M | 1.31M | |||
| Marketable Securities | 42.79M | 34.49M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 511.00K | 390.00K | 310.00K | 230.00K | 120.00K | |||
| Total Current Assets | 46.92M | 39.44M | 55.04M | 9.57M | 1.42M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.68M | 2.19M | 2.60M | 940.00K | 1.17M | |||
| Intangibles | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 31.00K | 30.00K | 50.00K | 30.00K | 840.00K | |||
| Total Non-Current Assets | 1.71M | 2.22M | 2.66M | 970.00K | 2.01M | |||
| TOTAL ASSETS | 48.63M | 41.66M | 57.70M | 10.54M | 3.43M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 310.00K | 0.00 | |||
| Accrued Expenses | 944.00K | 880.00K | 1.02M | 1.45M | 620.00K | |||
| Accounts Payable | 427.00K | 650.00K | 560.00K | 1.39M | 1.22M | |||
| Other Current Liabilities | N/A | N/A | N/A | 30.00K | 30.00K | |||
| Total Current Liabilities | 1.37M | 1.53M | 1.58M | 3.19M | 1.88M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.06M | 1.40M | 1.71M | 250.00K | 570.00K | |||
| Total Non-Current Liabilities | 1.06M | 1.40M | 1.71M | 250.00K | 560.00K | |||
| TOTAL LIABILITIES | 2.44M | 2.93M | 3.29M | 3.44M | 2.44M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -130.04M | -106.52M | -81.85M | -65.32M | -56.19M | |||
| Additional Paid In Capital | 176.24M | 145.25M | 136.26M | 72.42M | 57.18M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Shares Outstanding | 13.32M | 9.47M | 9.47M | 2.54M | 720.00K | |||
| Tangible Book Value per Share | 3.47 | 4.09 | 5.74 | 2.80 | 1.38 | |||
| Total Shareholders' Equity | 46.20M | 38.73M | 54.40M | 7.10M | 990.00K | |||
| TOTAL LIABILITIES AND EQUITY | 48.63M | 41.66M | 57.70M | 10.54M | 3.43M | |||
| Statistics | ||||||||
| Current Ratio | 34.23 | 25.78 | 34.84 | 3.00 | 0.76 | |||
| Return On Assets (ROA) | -48.35% | -59.22% | -28.65% | -92.41% | -222.45% | |||
| Return On Equity (ROE) | -50.90% | -63.70% | -30.39% | -137.18% | -770.71% | |||
All data in USD , ROIC based on taxRate of 0.21